Skip to main content
. 2016 Jul 25;2016:4595014. doi: 10.1155/2016/4595014

Table 2.

Table of PI3K, AKT, and mTOR inhibitors in development [4].

PI3K/AKT/mTOR pathway inhibitors
PI3K AKT mTOR
AZD6482 A-443654 AZD-8055
AR245408 (XL 147) AR-42 BGT226
BAY 80-6946 AR-67 (DB-67) Everolimus
BKM120 AZD5363 INK-128
BYL719 GSK690693 NVP-BEZ235
GDC-0941 KP372-1 ONC-01910
GDC-0980 MK-2206 OSI-027
GSK2636771 SR13668 PP-242
PF-04691502 Triciribine (API-2) Rapamycin (sirolimus)
PX-866 VIII Ridaforolimus
ONC-01910 VQD-002 (API-2) Temsirolimus
WYE-354